Suppr超能文献

Syndecan-4以PKCα依赖的方式调节内皮细胞中mTOR复合物2的亚细胞定位和Akt激活。

Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells.

作者信息

Partovian Chohreh, Ju Rong, Zhuang Zhen W, Martin Kathleen A, Simons Michael

机构信息

Angiogenesis Research Center, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.

出版信息

Mol Cell. 2008 Oct 10;32(1):140-9. doi: 10.1016/j.molcel.2008.09.010.

Abstract

Mammalian target of rapamycin (mTOR) activity is regulated by assembly of two functionally distinct complexes, mTORC1 and mTORC2. In syndecan-4 (S4) null endothelial cells, mTORC2 activity is reduced, resulting in decreased Akt activation, while mTORC1 activity is increased. Levels of rictor, mLST8, and mSin-1 are unchanged in total cell lysates but decreased in the rafts of S4(-/-) endothelial cells, as is the level of PKCalpha. Expression of myristoylated-PKCalpha in S4(-/-) cells restores rictor, mLST8, and mSin-1 presence in the rafts and rescues Akt phosphorylation. PKCalpha knockdown mimics the effect of S4 deletion on mTORC2 localization and Akt activation. Reduced mTORC2 activity in S4(-/-) endothelial cells results in decreased FoxO1/3a and eNOS phosphorylation, decreased endothelial cell size, and increased arterial blood pressure in S4(-/-) mice. Thus, S4-dependent targeting of PKCalpha to the plasma membrane is required for recruitment of mTORC2 components to the rafts and Akt activation.

摘要

雷帕霉素哺乳动物靶蛋白(mTOR)的活性受两种功能不同的复合物mTORC1和mTORC2组装的调节。在syndecan - 4(S4)基因缺失的内皮细胞中,mTORC2活性降低,导致Akt激活减少,而mTORC1活性增加。在总细胞裂解物中,rictor、mLST8和mSin - 1的水平未发生变化,但在S4(- / -)内皮细胞的脂筏中降低,PKCalpha的水平也是如此。在S4(- / -)细胞中表达肉豆蔻酰化的PKCalpha可恢复脂筏中rictor、mLST8和mSin - 1的存在,并挽救Akt磷酸化。敲低PKCalpha可模拟S4缺失对mTORC2定位和Akt激活的影响。S4(- / -)内皮细胞中mTORC2活性降低导致S4(- / -)小鼠中FoxO1/3a和eNOS磷酸化减少、内皮细胞大小减小以及动脉血压升高。因此,PKCalpha依赖S4靶向质膜是mTORC2组分募集到脂筏和Akt激活所必需的。

相似文献

2
Syndecan 4 regulation of PDK1-dependent Akt activation.
Cell Signal. 2013 Jan;25(1):101-5. doi: 10.1016/j.cellsig.2012.09.007. Epub 2012 Sep 10.
3
Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.
Mol Cell Biol. 2015 Apr;35(7):1299-313. doi: 10.1128/MCB.00306-14. Epub 2015 Jan 12.
5
mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
Mol Cell Biol. 2010 Feb;30(4):908-21. doi: 10.1128/MCB.00601-09. Epub 2009 Dec 7.
6
Rictor, an mTORC2 Protein, Regulates Murine Lymphatic Valve Formation Through the AKT-FOXO1 Signaling.
Arterioscler Thromb Vasc Biol. 2024 Sep;44(9):2004-2023. doi: 10.1161/ATVBAHA.124.321164. Epub 2024 Aug 1.
7
Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors.
Stem Cell Reports. 2014 Nov 11;3(5):832-40. doi: 10.1016/j.stemcr.2014.08.011. Epub 2014 Sep 25.
8
Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2.
Circ Res. 2007 Jan 5;100(1):79-87. doi: 10.1161/01.RES.0000253094.03023.3f. Epub 2006 Nov 16.
9

引用本文的文献

1
Towards the genome-scale discovery of bivariate monotonic classifiers.
BMC Bioinformatics. 2025 Sep 2;26(1):228. doi: 10.1186/s12859-025-06253-7.
2
Syndecans and glycosaminoglycans influence B-cell development and activation.
EMBO Rep. 2025 May;26(9):2435-2458. doi: 10.1038/s44319-025-00432-6. Epub 2025 Mar 28.
4
The mTORC2 signaling network: targets and cross-talks.
Biochem J. 2024 Jan 25;481(2):45-91. doi: 10.1042/BCJ20220325.
5
Characterization of wooden breast myopathy: a focus on syndecans and ECM remodeling.
Front Physiol. 2023 Dec 5;14:1301804. doi: 10.3389/fphys.2023.1301804. eCollection 2023.
6
COVID-19 of differing severity: from bulk to single-cell expression data analysis.
Cell Cycle. 2023 Jul-Aug;22(14-16):1777-1797. doi: 10.1080/15384101.2023.2239620. Epub 2023 Jul 24.
7
Syndecan-4 as a genetic determinant of the metabolic syndrome.
Diabetol Metab Syndr. 2023 Jul 17;15(1):156. doi: 10.1186/s13098-023-01132-8.

本文引用的文献

1
Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling.
EMBO J. 2008 Jul 23;27(14):1919-31. doi: 10.1038/emboj.2008.119. Epub 2008 Jun 19.
2
Expanding mTOR signaling.
Cell Res. 2007 Aug;17(8):666-81. doi: 10.1038/cr.2007.64.
4
Akt1 in endothelial cell and angiogenesis.
Cell Cycle. 2006 Mar;5(5):512-8. doi: 10.4161/cc.5.5.2538. Epub 2006 Mar 1.
5
mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes.
J Biol Chem. 2005 Dec 9;280(49):40406-16. doi: 10.1074/jbc.M508361200. Epub 2005 Oct 11.
6
PKCalpha activates eNOS and increases arterial blood flow in vivo.
Circ Res. 2005 Sep 2;97(5):482-7. doi: 10.1161/01.RES.0000179775.04114.45. Epub 2005 Aug 4.
7
The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.
J Biol Chem. 2005 May 27;280(21):20814-23. doi: 10.1074/jbc.M500528200. Epub 2005 Mar 21.
8
Syndecans: new kids on the signaling block.
Circ Res. 2005 Mar 18;96(5):488-500. doi: 10.1161/01.RES.0000159708.71142.c8.
9
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
Science. 2005 Feb 18;307(5712):1098-101. doi: 10.1126/science.1106148.
10
Effect of overexpression of constitutively active PKCalpha on rat lacrimal gland protein secretion.
Invest Ophthalmol Vis Sci. 2004 Nov;45(11):3974-81. doi: 10.1167/iovs.04-0508.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验